Sign In to Follow Application
View All Documents & Correspondence

A Kit Comprising: I) A Composition Of Mesenchymal Stromal Cells, And Ii) Hyaluronic Acid And Treatment Of Osteoarthritis Thereof

Abstract: The present disclosure relates to an ultrasound guided intraarticular administration of a combination of a composition comprising pooled mesenchymal stromal cells, and mid molecular weight hyaluronic acid for treatment of osteoarthritis. The disclosure also provides methods for increasing levels of anti-inflammatory marker and decreasing levels of disease progression marker in a human subject suffering from osteoarthritis through the use of the said combination. The present disclosure accordingly also relates to a kit comprising the said composition and the hyaluronic acid as such for the said use and treatment.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
07 December 2022
Publication Number
04/2023
Publication Type
INA
Invention Field
BIO-CHEMISTRY
Status
Email
IPO@knspartners.com
Parent Application
Patent Number
Legal Status
Grant Date
2024-01-05
Renewal Date

Applicants

STEMPEUTICS RESEARCH PRIVATE LIMITED
3rd Floor, Manipal Hospital Whitefield Pvt. Ltd. #143, 212-215, EPIP Industrial Area, ITPL Main Road, Bengaluru – 560066, Karnataka, India.

Inventors

1. PAWAN KUMAR GUPTA
3rd Floor, Manipal Hospital Whitefield Pvt. Ltd. #143, 212-215, EPIP Industrial Area, ITPL Main Road, Bengaluru – 560066, Karnataka, India.
2. UDAYKUMAR KOLKUNDKAR
3rd Floor, Manipal Hospital Whitefield Pvt. Ltd. #143, 212-215, EPIP Industrial Area, ITPL Main Road, Bengaluru – 560066, Karnataka, India.
3. SHIVASHANKAR PARASHURAM
3rd Floor, Manipal Hospital Whitefield Pvt. Ltd. #143, 212-215, EPIP Industrial Area, ITPL Main Road, Bengaluru – 560066, Karnataka, India.
4. SURESH KANNAN SUBRAMANIAN SHANMUGAM
3rd Floor, Manipal Hospital Whitefield Pvt. Ltd. #143, 212-215, EPIP Industrial Area, ITPL Main Road, Bengaluru – 560066, Karnataka, India.

Specification

We claim:
1. A combination product or a kit, comprising a combination of:
• a composition comprising about 20 to 30 million mesenchymal stromal cells,
5 about 1 ml of multiple electrolyte solution and about 1 ml of protein free, serum
free, animal component free formulation of about 2.5% to 5% dimethyl
sulfoxide (DMSO); and
• about 2 ml of mid molecular weight hyaluronic acid,
wherein the composition is devoid of human serum albumin (HSA); and wherein the
mesenchymal stromal cells are bone marrow derived pooled mesenchymal stromal cells
obtained from pooling mesenchymal stromal cells from at least 3 donors.
2. The product or the kit as claimed in claim 1, wherein the multiple electrolyte solution
is Plasmalyte A.

3. The product or the kit as claimed in claim 1, wherein the composition comprises 25
million pooled mesenchymal stromal cells.
4. The product or the kit as claimed in claim 1, wherein the combination is employed for
treatment of Grade II or Grade III osteoarthritis.

Documents

Application Documents

# Name Date
1 202241070687-STATEMENT OF UNDERTAKING (FORM 3) [07-12-2022(online)].pdf 2022-12-07
2 202241070687-REQUEST FOR EXAMINATION (FORM-18) [07-12-2022(online)].pdf 2022-12-07
3 202241070687-REQUEST FOR EARLY PUBLICATION(FORM-9) [07-12-2022(online)].pdf 2022-12-07
4 202241070687-POWER OF AUTHORITY [07-12-2022(online)].pdf 2022-12-07
5 202241070687-FORM-9 [07-12-2022(online)].pdf 2022-12-07
6 202241070687-FORM FOR SMALL ENTITY(FORM-28) [07-12-2022(online)].pdf 2022-12-07
7 202241070687-FORM FOR SMALL ENTITY [07-12-2022(online)].pdf 2022-12-07
8 202241070687-FORM 18 [07-12-2022(online)].pdf 2022-12-07
9 202241070687-FORM 1 [07-12-2022(online)].pdf 2022-12-07
10 202241070687-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [07-12-2022(online)].pdf 2022-12-07
11 202241070687-DRAWINGS [07-12-2022(online)].pdf 2022-12-07
12 202241070687-DECLARATION OF INVENTORSHIP (FORM 5) [07-12-2022(online)].pdf 2022-12-07
13 202241070687-COMPLETE SPECIFICATION [07-12-2022(online)].pdf 2022-12-07
14 202241070687-Power of Attorney [11-01-2023(online)].pdf 2023-01-11
15 202241070687-Form 1 (Submitted on date of filing) [11-01-2023(online)].pdf 2023-01-11
16 202241070687-Covering Letter [11-01-2023(online)].pdf 2023-01-11
17 202241070687-Proof of Right [18-01-2023(online)].pdf 2023-01-18
18 202241070687-MSME CERTIFICATE [19-01-2023(online)].pdf 2023-01-19
19 202241070687-FORM28 [19-01-2023(online)].pdf 2023-01-19
20 202241070687-FORM 18A [19-01-2023(online)].pdf 2023-01-19
21 202241070687-FER.pdf 2023-02-07
22 202241070687-FORM 3 [12-04-2023(online)].pdf 2023-04-12
23 202241070687-OTHERS [06-07-2023(online)].pdf 2023-07-06
24 202241070687-FER_SER_REPLY [06-07-2023(online)].pdf 2023-07-06
25 202241070687-CLAIMS [06-07-2023(online)].pdf 2023-07-06
26 202241070687-US(14)-HearingNotice-(HearingDate-18-12-2023).pdf 2023-12-06
27 202241070687-US(14)-ExtendedHearingNotice-(HearingDate-27-12-2023).pdf 2023-12-14
28 202241070687-Correspondence to notify the Controller [26-12-2023(online)].pdf 2023-12-26
29 202241070687-Written submissions and relevant documents [03-01-2024(online)].pdf 2024-01-03
30 202241070687-PatentCertificate05-01-2024.pdf 2024-01-05
31 202241070687-IntimationOfGrant05-01-2024.pdf 2024-01-05

Search Strategy

1 SearchHistoryE_07-02-2023.pdf

ERegister / Renewals

3rd: 14 Jun 2024

From 07/12/2024 - To 07/12/2025

4th: 30 Oct 2025

From 07/12/2025 - To 07/12/2026